Special Issue "Recent Progress in Foamy Virus (FV) Research"

Quicklinks

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".

Deadline for manuscript submissions: closed (31 October 2013)

Special Issue Editors

Lead Guest Editor
Dr. Arifa S. Khan
Senior Investigator, Laboratory of Retroviruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, 8800 Rockville Pike, HFM-454, Bldg 29B, Room 4NN10, Bethesda, MD 20892 USA
Website: http://fdazilla.com/fda/directory/employee/arifa.khan@fda.hhs.gov
E-Mail: arifa.khan@fda.hhs.gov
Phone: +301 827 0791
Fax: +301 496 1810

Co-Guest Editor
Prof. Dr. Martin Löchelt
Group Leader, German Cancer Research Center (DKFZ), Research Program Infection Center, Department Genome Modifications and Carcinogenesis (F020), Im Neuenheimer Feld 242, D-69120 Heidelberg, Germany
Website: http://www.dkfz.de/de/f020/groups/loechelt/people.html
E-Mail: m.loechelt@dkfz.de
Phone: +49 6221 42 4933
Fax: +49 6221 42 4932

Co-Guest Editor
Prof. Dr. Axel Rethwilm
Professor and Chair, Universität Würzburg, Institut für Virologie und Immunbiologie, Versbacher Str. 7, 97078 Wurzburg, Germany
Website: http://www.virologie.uni-wuerzburg.de/
E-Mail: Rethwilm@vim.uni-wuerzburg.de
Phone: +49 931 201 49555
Fax: +49 931 201 49553

Special Issue Information

Dear Colleagues,

Foamy viruses are ancient retroviruses that naturally occur in non-human primate species and in a variety of other animal species including bovine, equine, and feline. However, human foamy virus infections have been shown to be due to cross-species transmission from infected non-human primates. Although there is no evidence thus far of FV pathogenesis in any species, human exposure should be minimized since infectious foamy virus can stably persist life-long. Studies of virus replication and latency, virus prevalence in the natural host, and human infections can contribute to evaluating  the potential risks of FV infection in humans. Based upon several unique properties of these ancient retroviruses and the lack of known pathogenicity, foamy viruses are being developed as novel vectors for targeted gene delivery and vaccination, with recent improvements for new applications in experimental systems and medicine.

The main focus of this special issue is to review the current knowledge of FVs and present an update of FV research. The topics will include, but not limited to:

  • Simian and non-simian FVs: Overview
  • Natural infections
  • Zoonoses
  • Evolution
  • Molecular Biology and Replication
  • Viral proteins
  • FV vectors
  • Restriction factors
  • Antivirals
  • Virus detection assays
  • Management of potential sources of exposure and infection

Dr. Arifa S. Khan
Prof. Dr. Martin Löchelt
Prof. Dr. Axel Rethwilm
Guest Editors

Published Papers (11 papers)

by  and
Viruses 2013, 5(10), 2349-2374; doi:10.3390/v5102349
Received: 5 August 2013; in revised form: 27 August 2013 / Accepted: 18 September 2013 / Published: 25 September 2013
Show/Hide Abstract | PDF Full-text (380 KB) | HTML Full-text | XML Full-text

by ,  and
Viruses 2013, 5(9), 2169-2209; doi:10.3390/v5092169
Received: 8 August 2013; in revised form: 4 September 2013 / Accepted: 5 September 2013 / Published: 13 September 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (38407 KB) | HTML Full-text | XML Full-text

by ,  and
Viruses 2013, 5(7), 1850-1866; doi:10.3390/v5071850
Received: 24 June 2013; in revised form: 12 July 2013 / Accepted: 12 July 2013 / Published: 18 July 2013
Show/Hide Abstract | PDF Full-text (236 KB) | HTML Full-text | XML Full-text

by , , , , , , , ,  and
Viruses 2013, 5(7), 1702-1718; doi:10.3390/v5071702
Received: 1 March 2013; in revised form: 13 June 2013 / Accepted: 25 June 2013 / Published: 12 July 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (355 KB) | HTML Full-text | XML Full-text

by  and
Viruses 2013, 5(6), 1536-1552; doi:10.3390/v5061536
Received: 15 May 2013; in revised form: 9 June 2013 / Accepted: 10 June 2013 / Published: 19 June 2013
Show/Hide Abstract | PDF Full-text (19770 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Viruses 2013, 5(6), 1414-1430; doi:10.3390/v5061414
Received: 25 April 2013; in revised form: 22 May 2013 / Accepted: 30 May 2013 / Published: 6 June 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (477 KB) | HTML Full-text | XML Full-text
abstract graphic

by ,  and
Viruses 2013, 5(4), 1075-1098; doi:10.3390/v5041075
Received: 4 February 2013; in revised form: 25 March 2013 / Accepted: 29 March 2013 / Published: 10 April 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (815 KB) | HTML Full-text | XML Full-text

by ,  and
Viruses 2013, 5(4), 1055-1074; doi:10.3390/v5041055
Received: 27 February 2013; in revised form: 28 March 2013 / Accepted: 29 March 2013 / Published: 8 April 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (1445 KB) | HTML Full-text | XML Full-text

by
Viruses 2013, 5(4), 1023-1041; doi:10.3390/v5041023
Received: 25 January 2013; in revised form: 15 March 2013 / Accepted: 20 March 2013 / Published: 26 March 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (846 KB) | HTML Full-text | XML Full-text

by ,  and
Viruses 2013, 5(3), 886-900; doi:10.3390/v5030886
Received: 31 January 2013; in revised form: 11 March 2013 / Accepted: 14 March 2013 / Published: 20 March 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (306 KB) | HTML Full-text | XML Full-text

by , ,  and
Viruses 2012, 4(12), 3572-3588; doi:10.3390/v4123572
Received: 15 October 2012; in revised form: 19 November 2012 / Accepted: 28 November 2012 / Published: 7 December 2012
Show/Hide Abstract | Cited by 4 | PDF Full-text (229 KB) | HTML Full-text | XML Full-text

Last update: 23 October 2013

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert